noel, i think you have hit the nail on the head. EXS is in play thats for sure, and any deal from here would see IVA or someone else offer us a deal for the whole company.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025